Flying The Web For News.
  • New Year's
    New Year's
  • Career Exam Study
    Career Exam Study
  • 2024 Presidential Election
    2024 Presidential Election
  • E-commerce Guide
    E-commerce Guide
  • Dropshipping Guide
    Dropshipping Guide
  • Microsoft Exam
    Microsoft Exam
  • IT Career News
    IT Career News
+ Larger Font | - Smaller Font
Share

Globe NewsWire News Distribution Service


MENLO PARK, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced SPRQ, an improved sequencing chemistry for its Revio™ long-read sequencing system. The new chemistry will reduce Revio DNA input requirements by 4x to 500ng per sample, which enables more sample types such…


Posted: 2024-10-29 13:05:00

Get Full News Story On GlobeNewsWire Press Release Service



Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.



Related News Stories From The Web And More

Related Bing News Search Results

Press Release: PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 - Newscast

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

Thu, 07 Nov 2024 13:03:00 GMT PacBio products are provided for Research Use Only. Not for use in diagnostic procedures. Forward-Looking Statements: This press release contains “forward-looking statements” ...

PacBio Announces Third Quarter 2024 Financial Results

Thu, 07 Nov 2024 08:05:00 GMT With the launch of our SPRQ chemistry and the Vega benchtop ... GAAP and non‐GAAP financial measures included in this press release. PacBio excludes recurring charges from its non-GAAP financial ...

PacBio Announces Third Quarter 2024 Financial Results

Wed, 06 Nov 2024 16:00:00 GMT With the launch of our SPRQ chemistry ... PacBio's financial measures under GAAP include substantial charges that are listed in the itemized reconciliations between GAAP and non‐GAAP financial ...

PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028

Wed, 06 Nov 2024 16:00:00 GMT MENLO PARK, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that it has entered into a ...

PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to Less Than $500

Tue, 29 Oct 2024 17:01:00 GMT PacBio (NASDAQ: PACB), announced SPRQ ... In addition, a SMRT Link and instrument software upgrade paired with the release of SPRQ chemistry provides new DNA methylation callers that greatly increase ...


Blow Us A Whistle